Association Between Cystatin C and 1-Year Readmission Risk in Heart Failure Patients with or without Chronic Kidney Disease

Global Journal of Cardiovascular Diseases | Vol 5, Issue 1

Figure 2

Kaplan-Meier curves for 1-year readmission by CysC tertiles. Cumulative incidence of readmission is stratified by CysC levels (T1: <1.36 mg/L, T2: 1.36-1.98mg/L, T3: >1.98 mg/L). (A) Among non-CKD HF patients, readmission risk increased significantly across higher tertiles (log-rank <i>p</i> < 0.001). (B) No significant association was observed among CKD patients (log-rank<i> p</i> = 0.587).

Figure 2. Kaplan-Meier curves for 1-year readmission by CysC tertiles. Cumulative incidence of readmission is stratified by CysC levels (T1: <1.36 mg/L, T2: 1.36-1.98mg/L, T3: >1.98 mg/L). (A) Among non-CKD HF patients, readmission risk increased significantly across higher tertiles (log-rank p < 0.001). (B) No significant association was observed among CKD patients (log-rank p = 0.587).